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INTRODUCTION
Pre-eclampsia is a specific gestational disorder,
which occupies approximately 3-5% from whole
number of pregnancy. The manifestation seen in
the pregnant mother varies from mild hyperten-
sion, severe/critical hypertension, eclampsia to
HELLP syndrome (hemolysis, elevated liver en-
zyme, low platelet count). Meanwhile, in the fetus,
the manifestation of this disorder also varies from
premature birth, retarded fetal growth, to fetal
death.
In the US, the number of incident of pre-eclamp-
sia is approximately 5% of all pregnancy, and about
0.5-2% from them will develop into eclampsia,
which is the second most common cause of death
in pregnancy after thromboembolic disease. In In-
donesia, the incident varies from 2.1-8.5%. In Sang-
lah Hospital Denpasar, from the study conducted
by Ardhana (1997), the incident of preeclampsia is
1.8%. Meanwhile, Oka and Surya (2002-2003) re-
ported that the incident is as much as 5.83% from
7552 number of labor within the duration of the
study. By comparing these two studies, we can con-
Abstract
Objective: To define that elevated TNF-α serum level was the risk
factor of preeclampsia in pregnancy.
Method: This research is a case-control study. From 56 pregnant
women, there are 28 women with preeclampsia and the other 28
women with normal pregnancy. Then the serum level of TNF-α was
obtained at Prodia’s clinical Laboratory Denpasar. Data’s normality
test was done with Kolmogorov-Smirnov, then an analysis of data
was done with Independent Sample Test, predictive value a = 0.05.
To define the role of TNF-α level in preeclampsia, Chi-Square test
was chosen.
Result: From this research we found the average level of TNF-α in
preeclampsia (6.64 ± 7.64 pg/ml) was higher than in normal preg-
nancy (2.42 ± 1.77 pg/ml). Analysis with t-independent test shows
that the t-value was 2.85 and p-value was 0.006, which means that
the average level of TNF-α between the two group was significantly
different (with predictive value, p<0.05). Based on cut-off value 2.42
pg/ml, the relative risk for preeclampsia was six time (RO = 6.33, IK
95%=1.97-20.34, p = 0.001) in patient with TNF-α level greater than
2.42 pg/ml.
Conclusion: TNF-α level in preeclampsia was significantly different
with TNF-α level in normal pregnancy and the elevated serum level
of TNF-α in pregnancy could be one of the risk for preeclampsia.
[Indones J Obstet Gynecol 2012; 36-3: 107-11]
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Abstrak
Tujuan: Untuk mengetahui apakah peningkatan kadar serum TNF-α
merupakan factor risiko terjadinya preeklampsia pada kehamilan.
Metode: Penelitian ini merupakan studi kasus-kontrol. Dari 56 orang
ibu hamil, didapatkan 28 ibu hamil dengan preeklampsia dan 28 de-
ngan kehamilan normal. Selanjutnya dilakukan pemeriksaan kadar
serum TNF-α di laboratorium klinik Prodia Denpasar. Dari data yang
terkumpul dilakukan pengujian normalitas data dengan Kolmogorov-
Smirnov, kemudian dilakukan analisis data dengan independent sam-
ple test dengan tingkat kemaknaan a=0,05. Untuk mengetahui pe-
ranan kadar TNF-α terhadap preeklampsia dipakai uji Chi-Square.
Hasil: Dari penelitian ini didapatkan kadar rerata TNF-α pada pre-
eklampsia 6,64 ± 7,64 pg/ml lebih tinggi dari kehamilan normal de-
ngan kadar rerata TNF-α 2,42 ± 1,77 pg/ml. Analisis kemaknaan de-
ngan uji t-independent menunjukkan bahwa nilai t = 2,85 dan nilai
p=0,006. Hal ini berarti bahwa rerata kadar TNF-α pada kedua kelom-
pok berbeda secara bermakna (p<0,05). Berdasarkan nilai titik potong
2,42 pg/ml, didapatkan bahwa risiko relatif terjadinya preeklampsia
adalah sebesar 6 kali (RO = 6,33; IK 95% = 1,97-20,34; p=0,001).
Kesimpulan: Kadar TNF-α pada preeklampsia berbeda secara ber-
makna dibandingkan dengan kadar TNF-α kehamilan normal. Dan
adanya peningkatan kadar serum TNF-α pada kehamilan dapat
berisiko terjadinya preeklampsia.
[Maj Obstet Ginekol Indones 2012; 36-3: 107-11]
Kata kunci: kehamilan normal, preeklampsia, TNF-α
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clude that the incident of preeclampsia is increas-
ing during the previous 3-4 years.1
Based on the Working Group of The National
High Blood Pressure Education Programme (NHBPEP),
the diagnosis of preeclampsia is established when
there is an increment in blood pressure by
≥140/90 mmHg after the 20th week of gestational
age, followed by proteinuria ≥300mg/24 hours or
from dipstick test result of ≥1+.2-5
The early cause of preeclampsia is still un-
known; the latest development tries to explain
about an underlying molecular mechanism and
most importantly the abnormal development, pla-
cental hypoxia, and endothelial dysfunction. Cyto-
kine is a messenger protein secreted by inflamma-
tory cell and immune cell, so as for growth factor,
oncogene, chemokine, and another dissolved factor
which influencing the differentiation of growth and
viability of the cell. Cytokine is divided into 6
groups: interleukin, colony-stimulating factor, in-
terferon, tumor necrosis factor, growth factor, and
chemokine. Some type of cytokine is proven to be
increased in preeclampsia and it probably can be
used as a marker of preeclampsia.4.6-7
The inflammatory cytokines, such as IL-6 and
TNF−α, are reported to be increased in preeclamp-
sia. But the importance of those cytokine in medi-
ating the cardiovascular and renal dysfunction, as
the response towards placental ischemia during
pregnancy is not fully established. From the study
using pregnant mice, the important role of TNF−α
and IL-6 in mediating hypertension and decreased
renal hemodynamic can be observed during the re-
duction of uterine perfusion pressure.8
The purpose of this study is to describe the role
of TNF−α in preeclampsia, since several studies re-
ported contradictory result, where the correlation
between the increase in serum level of TNF−α and
the incident of preeclampsia is not significant.10
METHOD
The study design was case-control study non-
paired. The population of the case and control
group is pregnant mother with preeclampsia and
mother with normal pregnancy, respectively, who
came to Emergency Department and Polyclinic of
Obstetrics and Gynecology of Sanglah Hospital
Denpasar during the period of July 2010-2011. The
inclusion criteria was pregnant woman who came
to Emergency Department and Polyclinic of Obstet-
rics and Gynecology of Sanglah Hospital Denpasar
with gestational age more than 20 weeks and will-
ing to be included in the study. The exclusion cri-
teria were pregnant woman with diabetes mellitus,
renal disorder, cardiovascular disorder, chronic hy-
pertension, premature rupture of the membrane,
clinical sign of infection, twin pregnancy, and in-
trauterine fetal death. The patients who match all
the criteria for the study sample was then further
informed about the study detail and the consent
was obtained.
The method for the serum level investigation of
TNF−α was using the reagent set Quantikine HS
Human TNF−α Immunoassay product R&D system
Minneapolis with the standard range 0.5-32 pg/ml
detection limit 0.106 pg/ml.11 The data was col-
lected and analysed using computer programme
Statistical Product and Service Solution (SPSS) for
Windows version 16.0.
RESULT
During the study, 56 pregnant patients were in-
cluded as the sample of this research after fulfilling
the inclusion criteria and devoid of exclusion crite-
ria. They were further divided into case and control
group, each consists of 28 mothers. The charac-
teristic data of the subject from respective group
are presented in Table 1.
Table 1. Age Average, Gestational Age, Parity, and Level
of TNF−α from Case Group and Control Group
Variable
Pregnant
p
Preeclampsia (Case)
(n=28)
Normal (Control)
(n=28)
Age (yr) 29.04±7.66 26.36±5.45 0.137
Gestational Age (wk) 35.96±4.11 37.21±3.85 0.245
Parity  0.68±0.95  0.64±0.78 0.878
Level of TNF−α  6.64±7.64  2.42±1.77 0.006
Table 1 above showed that the average maternal
age of the case group and control group is
29.04±7.66 years and 26.36±5.45 years, respec-
tively. The average gestational age of the case
group and control group is 35.96±4.11 and
37.21±3.85 weeks, respectively. The average parity
of the case group and control group is 0.68±0.95
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and 0.64±0.78, respectively. The average level of
TNF−α of the case group and control group is
6.64 ±7.64 and 2.42±1.77. The analysis with inde-
pendentt-test on the maternal age, gestational age,
and parity, showed the p value of >0.05. This
means that there were no differences in those
three variables between the case and control
group. Meanwhile, the level of TNF−α of both
groups were significantly different with p = 0.006.
To identify the risk of incident of preeclampsia
on the high level of TNF−α, Chi-Square test was
used. The result is presented in Table 2.
Table 2 shows that the odd ratio of high level of
TNF−α (≥ 2.42 pq/ml) is 6.33 (OR = 6.33, CI 95%
= 1.97-20.34, p=0.001), meaning that subject with
high level of serum TNF−α is 6 times more likely
to suffer preeclampsia compared to the subject
with low level of serum TNF−α.
DISCUSSION
Preeclampsia is a specific pregnancy disorder that
complicates approximately 3-5% of pregnancy. The
incident of preeclampsia in Indonesia varies from
2.1%-8.5%, from that number, 4.91% causing death.
The early cause of preeclampsia is still unknown,
the latest development explaining the molecular
mechanism underlying the manifestation, most im-
portantly placental hypoxia and endothelial dys-
function. The factor that present before the endo-
thelial dysfunction such as increase of cytokine (IL-
6 and TNF−α) on the preeclampsia patient which
stimulates the activation of neutrophil and endo-
thelial dysfunction, lipid peroxydase resulting from
the breakdown of unsaturated lipid chain is in-
creased in preeclampsia, sincytiotrophoblast mi-
crovillus membrane affecting the activity of neu-
trophil and luminal endothelial cell growth that
further causing endothelial dysfunction.12-13
The over secretion of TNF−α will destroy the en-
dothelial cell, causing blood vessel occlusion, re-
ducing regional blood flow, and increasing the en-
dothelial permeability. One of the possible mecha-
nisms of preeclampsia is placental factor that in-
duce the monocyte and neutrophil to produce
TNF−α that causing endothelial disorder. Regard-
ing these reasons, the increase of TNF−α serum
level is assumed to be part of the pathogenesis of
preeclampsia. In normal pregnancy, TNF−α can
modify the growth and invasion of trophoblast on
the maternal spiral arteries. Apart from them, this
might contribute to abnormal formation of pla-
centa, oxidative stress and endothelial disorder.10
In this research, based on the case distribution
in both groups, the average maternal age for case
group and control group is 29.04±7.66 years and
26.36±5.45 years, respectively. The average gesta-
tional age in case group and control group is
35.96±4.11 weeks and 37.21±3.85 weeks, respec-
tively. The average parity in case group and control
group is 0.68±0.95 and 0.64±0.78, respectively. The
average TNF−α level in case group and control
group is 6.64±7.64 and 2.42±1.77, respectively. The
analysis of significance with t-independent test on
the variable of maternal age, gestational age, and
parity showed that the value of p>0.05. This means
that those three variables did not differ between
case group and control group. Meanwhile, on the
variable of TNF−α level showed the value of p =
0.006. It means that the average TNF−α level in
both groups vary significantly (p<0.05).
In the study conducted by Mihu, et al in 2008,
they reported that the TNF−α serum level in-
creased significantly in preeclampsia (14.15 pg/ml)
compared to normal pregnancy (5.71 pg/ml), with
p<0.001.9 In 2003, a study conducted by Muzam-
mil, et al in normal pregnancy, the TNF−α serum
level is 9.3±0.56 pg/ml, meanwhile in preeclampsia
is 67.66±61.83 pg/ml  (p<0.001).14
Another research conducted by Afshari et al in-
vestigated another cytokine, i.e. IL-6. It is reported
that the highest IL-6 serum level was found in
preeclampsia compared to normal pregnancy,
where the IL-6 serum level increased significantly
in preeclampsia 5.8 (4.85) pg/ml compared to nor-
mal pregnancy, 3.01 (2.45) pg/ml (p=0.02).15
Table 2. The Risk of Incident of Preeclampsia on TNF−α
Preeclampsia Normal Pregnancy OR CI 95% p
TNF-α
≥ 2.42 19  7
6.33 1.97–20.34 0.001
< 2.42  9 21
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Based on the analysis result using ROC curve,
the cut off point of TNF−α serum level between
case group (preeclampsia) and control group (nor-
mal pregnancy) is 2.42 with sensitivity and speci-
ficity value of 75% and 68%, respectively. To iden-
tify the risk for incident of preeclampsia in the
group with high level of TNF−α, Chi-Square test
was chosen. It was found that the odd ratio of high
TNF−α level (≥ 2.42 pg/ml) was 6.33 (OR = 6.33,
CI 95% = 1.97-20.34, p=0.001). From these data,
we concluded that the risk for preeclampsia in
pregnancy with high level of TNF−α is 6 times
higher. Considering those reasons, it is concluded
that the increase in TNF−α serum level in preg-
nancy may put the mother at risk of preeclampsia.
In this study, even though the risk of preeclampsia
was found to be 6 times higher in TNF−α serum
level of ≥ 2.42 pg/ml, the exact gestational age
when the TNF−α level starts to increase and when
the preeclampsia starts to develop in the condition
of increased TNF−α serum level could not be iden-
tified.
In a study conducted by Williams, et al in 1998,
it is reported that the odd ratio of TNF−α level
(sTNFp55) in eclampsia is 5.00 (OR = 5.00, CI 95%
= 1.20-20.92) and the odd ratio of sTNFp55 in pre-
eclampsia is 2.37 (OR = 2.37, CI 95% = 1.11-5.06.16
In the study conducted by Sanchez, et al in 2000,
it is reported that sTNFp55 serum level is 32.4%
higher in the case of preeclampsia (920.1±30.4 pg/ml)
compared to normal pregnancy (694.8±15.0 pg/ml,
t-test analysis p<0.001), with the odds ratio in
preeclampsia is 10.3 ( OR = 10.3, CI 95% = 4.1-
25.9).17
The difference in study design, gestational age
at the time of sampling, characteristic of subjects,
number of study population, and examination
method used by other researcher may give differ-
ent result from this study. We use reagent set
Quantikine HS Human TNF−α Immunoassay prod-
uct R&D system Minneapolis with standard range
of 0.5 - 32 pg/ml. detection limit 0,106 pg/ml as
the method of TNF−α serum level investigation.11
In a study conducted by Mihu, et.al. in 2008, the
method used in investigation of TNF−α serum level
is the immunometric sandwich EIA, human TNF−α
EIA kit 589201, Cayman Chemical Company, USA,
with detection limit of 1.5 pg/ml.9 Therefore, this
may be one of the factors causing the gap in the
result of study conducted by another researcher
and this study.
In this study, the huge increase in TNF−α serum
level (≥ 2.42 pq/ml) in a pregnancy can increase
the risk of preeclampsia by 6 times. Understanding
the risk factor of preeclampsia is very useful in
healthcare system for pregnant women to observe
the risk group in the early phase of pregnancy. It
should be used as a preeclampsia predictor and
one of the supporting diagnostic tools and as a pre-
dictor for prognosis of preeclampsia. In the sub-
sequent study, a more variable and greater number
of samples and longer duration of study are needed
to get more accurate and complete result regarding
the TNF−α as predictor of incident of preeclampsia.
CONCLUSION
TNF−α serum level differs in preeclampsia com-
pared to normal pregnancy and there is statisti-
cally significant difference between the two groups
(p<0.005), where the average TNF−α level in pree-
clampsia is higher than in normal pregnancy. The
huge increase in TNF−α serum level (≥ 2.42 pq/ml)
in pregnancy can increase the risk of incident of
preeclampsia by 6 times.
REFERENCES
1. Jaya Kusuma AAN. Manajemen Kegawatan Hipertensi Bi-
dang Obsteri. Majalah Penyakit Dalam Udayana. 2006; 7:
70-81.
2. Angsar MD. Hipertensi dalam kehamilan. Edisi 2. Surabaya:
Lab/SMF Obstetri Ginekologi, Fakultas Kedokteran
UNAIR/RSUD Dr Soetomo. 2003
3. Creasy RK, Resnik R. Pregnancy Related hypertension In
Maternal-fetal Medicine. 5th ed. USA:  Saunders. 2004; 859
- 99
4. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap L,
Wenstrom KD. In Hypertensive disorders in pregnancy.
Williams Obstetrics, 22nd ed New York: McGraw Hill. 2005.
808 - 61
5. Roeshadi RH. Dalam Upaya Menurunkan Angka Kesakitan
dan Angka Kematian Ibu pada Preeklampsia dan Eklampsia,
Fakultas Kedokteran Universitas Sumatera Utara. 2006:3-7.
6. Baumwell S, Karumanchi SA. In pre-eclampsia: Clinical
manifestations and molecular mechanisms. Nephron Clin-
Pract. Boston. 2007; 106:c72-c81
7. Desai P. Cytokines in Obstetrics and Gynaecology. J. Obstet-
Gynecol India. 2007; 57 (3) 205 - 09
8. LaMarca BD, Ryan MJ, Granger JP. Pathophisiology of Hy-
pertention During Peeclampsia: Role of Inflammatory Cy-
tokines in Current Hypertension reviews. Bentham Science
Publishers Ltd. 2007; 3: 69-74
9. Mihu D, Costin N, Blaga LG, Ciuchina S, Pop RB. Implication
of Tumor Necrosis Factor - Alpha in Preeclampsia. Applied
Medical Informatics. 2008; 23(3-4): 11 - 8
Indones J
110  Anom and Kusuma Obstet Gynecol
|
10. Roudsari FV, Ayati S, Ayatollahi H, Esmaeily H, Hasanzadeh
M, Shahabian M, Ali LP. Comparison of maternal serum Tu-
mor Necrosis Factor-alpha (TNF−α) in severe and mild
preeclampsia versus normal pregnancy. Iran J Reprod Med.
2009; 7(4): 153-6.
11. Anonimous. Quantikine Human TNF−α/TNFSF1A Im-
munassay. USA: Catalog number HSTA00C, R&D System,
Inc. 614 McKinley Place NE Minneapolis, 2009. MN 55413
12. Robson SC. Hypertension and renal disease in pregnancy.
Edmonds DK, editors. Dewhurst’s Textbook of obstetric and
Gynecology for Postgraduates, 6th ed. London: Blackwell
and Science Ltd. 199; 166-85. 
13. Manyonda IT. The immunology of preeclampsia. In: The Im-
munology of human reproduction. Taylor & Francis. Lon-
don, 2006:79-94
14. Muzammil S, Singhal U, Gulati R, Bano I. Serum Tumor Ne-
crosis Factor-α In Preeclampsia. Indian J Physiol Pharmacol,
2005; 49(2): 236 - 40.
15. Afshari JT, Ghomian N. Determination of Interleukin-6 and
Tumor Necrosis Factor-Alpha Concentrations in Iranian-
Khorasanian Patient with Preeclampsia. BMC Pregnancy
and Childbirth. 2005: 5-14
16. Williams MA, Mahomed K, Farrand A, Woelk GB, Mudzamiri
S, Madzime S, King IB, McDonald GB. Plasma tumor necrosis
factor-alpha soluble receptor p55 (sTNFp55) concentra-
tions in eclamptic, preeclamptic and normotensive preg-
nant Zimbabwean women. J Reprod Immunol. 1998; 40(2):
159-73.
17. Sanchez SE, Zhang C, Williams MA, Ware-Jauregui S, Lar-
rabure G, Bazul V, Farrand A. Tumor necrosis factor-alpha
soluble receptor p55 (sTNFp55) and risk of preeclampsia
in Peruvian women. J Reprod Immunol. 2000; 47(1):49-63.
Vol 36, No 3
July 2012 TNF-α is a risk factor for preeclampsia  111
|
